Synsam AB (publ) (SYNSAM.ST)

SEK 44.95

(1.24%)

EBITDA Summary of Synsam AB (publ)

  • Synsam AB (publ)'s latest annual EBITDA in 2023 was 1.71 Billion SEK , up 15.14% from previous year.
  • Synsam AB (publ)'s latest quarterly EBITDA in 2024 Q1 was 316 Million SEK , up 8.79% from previous quarter.
  • Synsam AB (publ) reported an annual EBITDA of 1.4 Billion SEK in 2022, up 1.11% from previous year.
  • Synsam AB (publ) reported an annual EBITDA of 879 Million SEK in 2021, up 29.57% from previous year.
  • Synsam AB (publ) reported a quarterly EBITDA of 449 Million SEK for 2024 Q2, up 30.64% from previous quarter.
  • Synsam AB (publ) reported a quarterly EBITDA of 471 Million SEK for 2023 Q2, up 24.27% from previous quarter.

Annual EBITDA Chart of Synsam AB (publ) (2023 - 2018)

Historical Annual EBITDA of Synsam AB (publ) (2023 - 2018)

Year EBITDA EBITDA Growth
2023 1.71 Billion SEK 15.14%
2022 1.4 Billion SEK 1.11%
2021 879 Million SEK 29.57%
2020 904 Million SEK 2.66%
2019 636.8 Million SEK 78.04%
2018 511.2 Million SEK 0.0%

Peer EBITDA Comparison of Synsam AB (publ)

Name EBITDA EBITDA Difference
AddLife AB (publ) 1.54 Billion SEK -10.673%
Biotage AB (publ) 432 Million SEK -296.065%
Bonesupport Holding AB (publ) 28.93 Million SEK -5812.845%
Doxa AB (publ) 296 Million SEK -478.041%
Elekta AB (publ) 3.29 Billion SEK 48.01%
iZafe Group AB (publ) -15.61 Million SEK 11056.009%
Ortivus AB (publ) -14.92 Million SEK 11563.219%
Ortivus AB (publ) -14.92 Million SEK 11563.219%
Q-linea AB (publ) -210.98 Million SEK 910.954%
S2Medical AB (publ) -13.52 Million SEK 12746.789%